Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
Open accessThe DOI matches its Crossref record; 186 of the 203 references it cites were found in a registry or an index.
Abstract
The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today. Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception. Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the molecular structure, general physiology, and pharmacology of distinct Nav channel subtypes. We discuss Nav channel ligands such as small molecules, toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody. Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit. Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clinical studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sodium channels are pseudo-heterotetrameric protein structures consisting of four highly similar domains, termed I, II, III, and IV (Figure 1). Each domain contains 6 membrane-spanning segments S1-S6 (Figure 1) [4] with S1-S4v forming the voltage-sensing domains and S5-S6 forming the pore loops and DEKA selectivity filter.”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [4]
Citations
Cites
1 retracted
Lee, J.-H., Park, C.-K., Chen, G., Han, Q., Xie, R.-G., Liu, T., Ji, R.-R., & Lee, S.-Y. (2014) · Cell · doi:10.1016/j.cell.2014.03.064 · Cited by 207
RetractedHodgkin, A. L., & Huxley, A. F. (1952) · The Journal of Physiology · doi:10.1113/jphysiol.1952.sp004764 · Cited by 23,191
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
The Economic Costs of Pain in the United States
Gaskin, D. J., & Richard, P. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.03.009 · Cited by 2,359
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.4 · Cited by 2,254
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
An SCN9A channelopathy causes congenital inability to experience pain
Cox, J. J., Reimann, F., Nicholas, A. K., Thornton, G., Roberts, E., Springell, K., Karbani, G., Jafri, H., Mannan, J., Raashid, Y., et al. (2006) · Nature · doi:10.1038/nature05413 · Cited by 1,600
The crystal structure of a voltage-gated sodium channel
Payandeh, J., Scheuer, T., Zheng, N., & Catterall, W. A. (2011) · Nature · doi:10.1038/nature10238 · Cited by 1,429
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
Akopian, A. N., Souslova, V., England, S., Okuse, K., Ogata, N., Ure, J., Smith, A., Kerr, B. J., McMahon, S. B., Boyce, S., et al. (1999) · Nature Neuroscience · doi:10.1038/9195 · Cited by 816
Research works printed but not linked: 6
- Nardi, 2012, Advances in targeting voltage-gated sodium channels with small molecules, ChemMedChem, 7, 1
- Moreau, 2014, Biophysics, pathophysiology, and pharmacology of ion channel gating pores, Front. Pharmacol., 3, 5
- Cestèle, 2013, Nonfunctional Nav1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects, Proc. Natl. Acad. Sci. U. S. A., 110, 17546, 10.1073/pnas.1309827110 · DOI
- (a) Convergence Pharmaceuticals’ Novel Nav1.7 Selective Sodium Channel Blocker CNV1014802 Demonstrates Proof of Concept in Second Neuropathic Pain Study in Lumbosacral Radiculopathy; Convergence Pharmaceuticals: Cambridge, UK, Sept23, 2014; http://www.convergencepharma.com/userfiles/file/140923_LSR_FINAL.pdf, (accessed Mar 20, 2015).
- (b) The Pipeline; Convergence Pharmaceuticals: Cambridge, UK, 2015; http://www.convergencepharma.com/?page_id=16, (accessed Mar 20, 2015).
- Kwong, 2013, Pharmacological Characterization Of GSK2339345, A Novel Voltage-Gated Sodium Channel Blocker For The Symptomatic Relief Of Cough, Am J. Resp. Crit. Care Med., 187, A4936
Cited by
RCSB Protein Data Bank: Enabling biomedical research and drug discovery
Goodsell, D. S., Zardecki, C., Di Costanzo, L., Duarte, J. M., Hudson, B. P., Persikova, I., Segura, J., Shao, C., Voigt, M., Westbrook, J. D., et al. (2020) · Protein Science · doi:10.1002/pro.3730 · Cited by 353
Progress in Understanding and Treating SCN2A-Mediated Disorders
Sanders, S. J., Campbell, A. J., Cottrell, J. R., Moller, R. S., Wagner, F. F., Auldridge, A. L., Bernier, R. A., Catterall, W. A., Chung, W. K., Empfield, J. R., et al. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.011 · Cited by 338
“Each domain containssixmembrane-spanningsegmentsS1–S6 (Figure1) [4]withS1–S4v forming thevoltagesensing domains and S5–S6 forming the pore loops and DEKA-selectivity filter.”
BackgroundStructural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist
Ahuja, S., Mukund, S., Deng, L., Khakh, K., Chang, E., Ho, H., Shriver, S., Young, C., Lin, S., Johnson, J. P., et al. (2015) · Science · doi:10.1126/science.aac5464 · Cited by 319
Angstrom-scale ion channels towards single-ion selectivity
Zhang, H., Li, X., Hou, J., Jiang, L., & Wang, H. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00582k · Cited by 294
Diversity of molecular targets and signaling pathways for CBD
de Almeida, D. L., & Devi, L. A. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.682 · Cited by 257
Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief
Emery, E. C., Luiz, A. P., & Wood, J. N. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1162295 · Cited by 222
Antibodies and venom peptides: new modalities for ion channels
Wulff, H., Christophersen, P., Colussi, P., Chandy, K. G., & Yarov-Yarovoy, V. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0013-8 · Cited by 182
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
Imbrici, P., Liantonio, A., Camerino, G. M., Bellis, M. D., Camerino, C., Mele, A., Giustino, A., Pierno, S., Luca, A. D., Tricarico, D., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00121 · Cited by 173
Krahn, A. D., Laksman, Z., Sy, R. W., Postema, P. G., Ackerman, M. J., Wilde, A. A. M., & Han, H. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.02.017 · Cited by 163
Restoring Vision to the Blind with Chemical Photoswitches
Tochitsky, I., Kienzler, M. A., Isacoff, E. Y., & Krämer, R. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00723 · Cited by 171
Krahn, A. D., Behr, E. R., Hamilton, R. M., Probst, V., Laksman, Z., & Han, H. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.12.001 · Cited by 159
Structural biology and molecular pharmacology of voltage-gated ion channels
Huang, J., Pan, X., & Yan, N. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00763-7 · Cited by 156
The chemistry and biology of guanidine natural products
Berlinck, R. G. S., & Romminger, S. (2015) · Natural Product Reports · doi:10.1039/c5np00108k · Cited by 130
Voltage-gated sodium channels in cancers
Liu, H., Weng, J., Huang, C. L.-H., & Jackson, A. P. (2024) · Biomarker Research · doi:10.1186/s40364-024-00620-x · Cited by 110
Zákány, F., Kovács, T., Panyi, G., & Varga, Z. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158706 · Cited by 104
The Neuroimmune Axis in Skin Sensation, Inflammation, and Immunity
Trier, A. M., Mack, M. R., & Kim, B. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801473 · Cited by 103
Recent advances in epilepsy genetics
Orsini, A. A., Zara, F., & Striano, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.014 · Cited by 95
Reducing CXCR4-mediated nociceptor hyperexcitability reverses painful diabetic neuropathy
Jayaraj, N. D., Bhattacharyya, B. J., Belmadani, A. A., Ren, D., Rathwell, C. A., Hackelberg, S., Hopkins, B. E., Gupta, H. R., Miller, R. J., & Menichella, D. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci92117 · Cited by 94
Swain, N. A., Batchelor, D. V., Beaudoin, S., Bechle, B. M., Bradley, P. A., Brown, A. D., Brown, B., Butcher, K. J., Butt, R. P., Chapman, M. L., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00598 · Cited by 94
Liu, W., Venugopal, S., Majid, S., Ahn, I. S., Diamante, G., Hong, J. S., Yang, X., & Chandler, S. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104877 · Cited by 90
Structure and Function of Ion Channels Regulating Sperm Motility—An Overview
Nowicka-Bauer, K., & Szymczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063259 · Cited by 94
Hanukoglu, I. (2016) · FEBS Journal · doi:10.1111/febs.13840 · Cited by 88
Tetrodotoxin: History, Biology, and Synthesis
Makarova, M., Rycek, L., Hájíček, J., Baidilov, D., & Hudlický, T. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901564 · Cited by 86
Asymmetric synthesis of batrachotoxin: Enantiomeric toxins show functional divergence against Na V
Logan, M. M., Toma, T., Thomas‐Tran, R., & Bois, J. D. (2016) · Science · doi:10.1126/science.aag2981 · Cited by 84
The pharmacology of voltage-gated sodium channel activators
Deuis, J. R., Mueller, A., Israel, M. R., & Vetter, I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.014 · Cited by 84
Huang, G., Liu, D., Wang, W., Wu, Q., Chen, J., Pan, X., Shen, H., & Yan, N. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110735 · Cited by 83
The chemistry and biology of guanidine natural products
Berlinck, R. G. S., Bertonha, A. F., Takaki, M., & Rodríguez, J. P. G. (2017) · Natural Product Reports · doi:10.1039/c7np00037e · Cited by 82
Structural Pharmacology of Voltage-Gated Sodium Channels
Noreng, S., Li, T., & Payandeh, J. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166967 · Cited by 80
Oxidative stress and ion channels in neurodegenerative diseases
Orfali, R., Alwatban, A. Z., Orfali, R. S., Lau, L., Chea, N., Alotaibi, A. M., Nam, Y.-W., & Zhang, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1320086 · Cited by 86
Focken, T., Liu, S., Chahal, N., Dauphinais, M., Grimwood, M., Chowdhury, S., Hemeon, I., Bichler, P., Bogucki, D. E., Waldbrook, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00447 · Cited by 79
Convergent Total Synthesis of Principinol D, a Rearranged Kaurane Diterpenoid
Turlik, A., Chen, Y., Scruse, A. C., & Newhouse, T. R. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03751 · Cited by 72
Voltage-gated sodium channels in excitable cells as drug targets
Alsaloum, M., Dib‐Hajj, S. D., Page, D. A., Ruben, P. C., Krainer, A. R., & Waxman, S. G. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01108-x · Cited by 75
Graceffa, R. F., Boezio, A. A., Able, J. A., Altmann, S., Berry, L., Boezio, C., Butler, J. R., Chu‐Moyer, M. Y., Cooke, M., DiMauro, E. F., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01850 · Cited by 70
Voltage-Gated Sodium Channel Dysfunctions in Neurological Disorders
Barbieri, R., Nizzari, M., Zanardi, I., Pusch, M., & Gavazzo, P. (2023) · Life · doi:10.3390/life13051191 · Cited by 75
Voltage-gated sodium channels: structures, functions, and molecular modeling
Xu, L., Ding, X., Wang, T., Mou, S., Sun, H., & Hou, T. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.05.014 · Cited by 76
Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
Horváth, B., Hézső, T., Kiss, D. Z., Kistamás, K., Magyar, J., Nánási, P. P., & Bányász, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00413 · Cited by 69
Scorpion Peptides and Ion Channels: An Insightful Review of Mechanisms and Drug Development
Mendes, L. C., Viana, G. M. M., Nencioni, A. L. A., Pimenta, D. C., & Beraldo-Neto, E. (2023) · Toxins · doi:10.3390/toxins15040238 · Cited by 67
Acute lamotrigine overdose: a systematic review of published adult and pediatric cases
Alyahya, B., Friesen, M., Nauche, B., & Laliberté, M. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1370096 · Cited by 66
Transmembrane Ion Channels: From Natural to Artificial Systems
Yan, T., & Liu, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202416200 · Cited by 67
Tetrodotoxin, a Potential Drug for Neuropathic and Cancer Pain Relief?
González‐Cano, R., Ruiz‐Cantero, M. C., Santos-Caballero, M., Gómez-Navas, C., Tejada, M. A., & Nieto, F. R. (2021) · Toxins · doi:10.3390/toxins13070483 · Cited by 63
Matrix metalloproteinases – From the cleavage data to the prediction tools and beyond
Cieplak, P., & Strongin, A. Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.03.010 · Cited by 63
Neuropathic pain: preclinical and early clinical progress with voltage-gated sodium channel blockers
Kushnarev, M., Pirvulescu, I., Candido, K. D., & Knežević, N. N. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1728254 · Cited by 68
Murray, J. K., Long, J., Zou, A., Ligutti, J., Andrews, K. L., Poppe, L., Biswas, K., Moyer, B. D., McDonough, S. I., & Miranda, L. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01947 · Cited by 61
Dormer, A., Narayanan, M., Schentag, J. J., Achinko, D., Norman, E., Kerrigan, J., Jay, G., & Heydorn, W. E. (2023) · Journal of Pain Research · doi:10.2147/jpr.s388896 · Cited by 59
Supramolecular Mechanosensitive Potassium Channel Formed by Fluorinated Amphiphilic Cyclophane
Sato, K., Sasaki, R., Matsuda, R., Nakagawa, M., Ekimoto, T., Yamane, T., Ikeguchi, M., Tabata, K. V., Noji, H., & Kinbara, K. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c04118 · Cited by 58
Bio‐inspired Two‐dimensional Nanofluidic Ionic Transistor for Neuromorphic Signal Processing
Mei, T., Liu, W., Sun, F., Chen, Y., Xu, G., Huang, Z., Jiang, Y., Wang, S., Chen, L., Liu, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202401477 · Cited by 56
Lin, Z., Santos, S., Padilla, K. M., Printzenhoff, D., & Castle, N. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161450 · Cited by 56
Kong, L., Yu, H., Deng, M., Wu, F., Jiang, Z., & Luo, T. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c01692 · Cited by 56
A mechanistic reinterpretation of fast inactivation in voltage-gated Na+ channels
Liu, Y., Bassetto, C. A. Z., Pinto, B. I., & Bezanilla, F. (2023) · Nature Communications · doi:10.1038/s41467-023-40514-4 · Cited by 55
Weiss, M. M., Dineen, T. A., Marx, I. E., Altmann, S., Boezio, A. A., Bregman, H. S., Chu‐Moyer, M. Y., DiMauro, E. F., Bojić, E. F., Foti, R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01851 · Cited by 55
Rothenberg, M. E., Tagen, M., Chang, J. H., Boyce‐Rustay, J. M., Friesenhahn, M. J., Hackos, D. H., Hains, A. B., Sutherlin, D., Ward, M. R., & Cho, W. C. S. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00807-3 · Cited by 54
Druggability of Voltage-Gated Sodium Channels—Exploring Old and New Drug Receptor Sites
Wisedchaisri, G., & El-Din, T. M. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.858348 · Cited by 55
Toxic medicine used in Traditional Chinese Medicine for cancer treatment: are ion channels involved?
Hengrui, L. (2022) · PubMed · doi:10.19852/j.cnki.jtcm.20220815.005 · Cited by 54
Kornecook, T. J., Yin, R., Altmann, S. M., Be, X., Berry, V. M., Ilch, C. P., Jarosh, M., Johnson, D., Lee, J. H., Lehto, S. G., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239590 · Cited by 56
New approaches to treating pain
Wolkerstorfer, A., Handler, N., & Buschmann, H. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.103 · Cited by 62
Nav1.7 inhibitors for the treatment of chronic pain
McKerrall, S. J., & Sutherlin, D. P. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.08.007 · Cited by 49
A structural atlas of druggable sites on Na v channels
Li, Z., Wu, Q., & Yan, N. (2023) · Channels · doi:10.1080/19336950.2023.2287832 · Cited by 52
Roecker, A. J., Egbertson, M. S., Jones, K. L., Gomez, R. P., Kraus, R. L., Li, Y., Koser, A. J., Urban, M. O., Klein, R. M., Clements, M. K., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.085 · Cited by 49
Self-citationWu, Y., Ma, H., Zhang, F., Zhang, C., Zou, X., & Cao, Z. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00406 · Cited by 48
Moyer, B. D., Murray, J. K., Ligutti, J., Andrews, K. L., Favreau, P., Jordan, J. B., Lee, J. H., Liu, D., Long, J., Sham, K. K. C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196791 · Cited by 48
Recent progress in non-opioid analgesic peptides
de Vega, M. J. P., Ferrer-Montiel, A. V., & González‐Muñiz, R. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.10.011 · Cited by 52
Kruth, K., Grisolano, T. M., Ahern, C. A., & Williams, A. J. (2020) · Molecular Autism · doi:10.1186/s13229-020-00330-9 · Cited by 51
Ion Channels Involvement in Neurodevelopmental Disorders
D’Adamo, M. C., Liantonio, A., Conte, E., Pessia, M., & Imbrici, P. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.032 · Cited by 48
Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain
Brimson, J. M., Brimson, S., Chomchoei, C., & Tencomnao, T. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1805435 · Cited by 46
DiMauro, E. F., Altmann, S. M., Berry, L., Bregman, H. S., Chakka, N., Chu‐Moyer, M. Y., Bojić, E. F., Foti, R., Fremeau, R. T., Gao, H., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00425 · Cited by 46
Marx, I. E., Dineen, T. A., Able, J. A., Bode, C., Bregman, H. S., Chu‐Moyer, M. Y., DiMauro, E. F., Du, B., Foti, R., Fremeau, R. T., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00243 · Cited by 45
Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics
Chew, L. A., Bellampalli, S. S., Dustrude, E. T., & Khanna, R. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.018 · Cited by 47
Acidosis-related pain and its receptors as targets for chronic pain
Hung, C., Chin, Y., Fong, Y.-O., Lee, C., Han, D., Lin, J.-H., Sun, W., & Chen, C. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108444 · Cited by 43
Hoelz, H., Herdl, C., Gerstl, L., Tacke, M., Vill, K., von Stülpnagel-Steinbeis, C., Rost, I., Hoertnagel, K., Abicht, A., Hollizeck, S., et al. (2019) · Clinical EEG and Neuroscience · doi:10.1177/1550059419876518 · Cited by 45
Pain pathways and potential new targets for pain relief
Wang, M., & Thyagarajan, B. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2086 · Cited by 45
Sodium Channels in Pain and Cancer
Luiz, A. P., & Wood, J. N. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2015.12.006 · Cited by 42
Wu, Y., Guernon, J. M., Shi, J., Ditta, J. L., Robbins, K. J., Rajamani, R., Easton, A. E., Newton, A. E., Bourin, C., Mosure, K. W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01918 · Cited by 41
A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy
Naimo, G. D., Guarnaccia, M., Sprovieri, T., Ungaro, C., Conforti, F. L., Andò, S., & Cavallaro, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153717 · Cited by 41
Sandercock, D. A., Barnett, M. W., Coe, J. E., Downing, A., Nirmal, A. J., Giminiani, P. D., Edwards, S. A., & Freeman, T. C. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00314 · Cited by 42
Dongol, Y., Cardoso, F. C., & Lewis, R. J. (2019) · Toxins · doi:10.3390/toxins11110626 · Cited by 41
Molecular dysregulation of ciliary polycystin-2 channels caused by variants in the TOP domain
Vien, T. N., Wang, J., Ng, L. C. T., Cao, E., & DeCaen, P. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920777117 · Cited by 41
Voltage-Gated Sodium Channels: A Prominent Target of Marine Toxins
Mackieh, R., Nader, R. A., Wehbe, R., Mattei, C., Legros, C., Fajloun, Z., & Sabatier, J. (2021) · Marine Drugs · doi:10.3390/md19100562 · Cited by 41
Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy
Agbo, J., Ibrahim, Z. G., Magaji, S. Y., Mutalub, Y. B., Mshelia, P. P., & Mhya, D. H. (2023) · Acta Epileptologica · doi:10.1186/s42494-023-00127-2 · Cited by 40
Ayala, M. R., Syrovets, T., Häfner, S., Zablotskii, V., Dejneka, A., & Simmet, T. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.031 · Cited by 40
Ceylan, H. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01893-9 · Cited by 45
Sun, S., Jia, Q., Zenova, A., Wilson, M. S., Chowdhury, S., Focken, T., Li, J., Decker, S., Grimwood, M., Andrez, J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01621 · Cited by 40
Pero, J. E., Rossi, M., Lehman, H. D. G. F., Kelly, M. J., Mulhearn, J. J., Wolkenberg, S. E., Cato, M. J., Clements, M. K., Daley, C. J., Filzen, T. M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.040 · Cited by 38
Self-citationSelective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7
Payandeh, J., & Hackos, D. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_97 · Cited by 39
Lin, M.-H., Chou, H.-C., Chen, Y.-F., Liu, W., Lee, C.-C., Liu, L. Y., & Chuang, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33577-7 · Cited by 38
The Role of Toxins in the Pursuit for Novel Analgesics
Maatuf, Y., Geron, M., & Priel, A. (2019) · Toxins · doi:10.3390/toxins11020131 · Cited by 39
Structural and Functional Analyses of Cone Snail Toxins
Duque, H. M., Dias, S. C., & Franco, O. L. (2019) · Marine Drugs · doi:10.3390/md17060370 · Cited by 38
Samarium( ii ) iodide-mediated reactions applied to natural product total synthesis
Heravi, M. M., & Nazari, A. (2022) · RSC Advances · doi:10.1039/d1ra08163b · Cited by 38
New Mendelian Disorders of Painlessness
Nahorski, M. S., Chen, Y., & Woods, C. G. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.010 · Cited by 37
Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel
Baumruck, A. C., Tietze, D., Steinacker, L. K., & Tietze, A. A. (2018) · Chemical Science · doi:10.1039/c8sc00004b · Cited by 37
Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels
Vaičiulevičiūtė, R., Bironaitė, D., Uzielienė, I., Mobasheri, A., & Bernotienė, E. (2021) · Cells · doi:10.3390/cells10102572 · Cited by 38
High-Throughput Screening of Na V 1.7 Modulators Using a Giga-Seal Automated Patch Clamp Instrument
Chambers, C., Witton, I., Adams, C., Marrington, L., & Kammonen, J. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.700 · Cited by 39
Pharmacotherapeutic management of trigeminal neuropathic pain: an update
Pergolizzi, J. V., Gharibo, C. G., Magnusson, P., Breve, F., LeQuang, J. A., & Varrassi, G. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2087507 · Cited by 36
SCN1A channelopathies: Navigating from genotype to neural circuit dysfunction
Bryson, A., & Petrou, S. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173460 · Cited by 37
Machine Learning Generation of Dynamic Protein Conformational Ensembles
Zheng, L.-E., Barethiya, S., Nordquist, E. B., & Chen, J. (2023) · Molecules · doi:10.3390/molecules28104047 · Cited by 36
Discovery, structure, and chemical synthesis of disulfide-rich peptide toxins and their analogs
Fang, G., Chen, X., Yang, Q., Zhu, L.-J., Li, N., Yu, H., & Meng, X. (2018) · Chinese Chemical Letters · doi:10.1016/j.cclet.2018.02.002 · Cited by 36
Focken, T., Burford, K., Grimwood, M., Zenova, A., Andrez, J., Gong, W., Wilson, M., Taron, M., Decker, S., Lofstrand, V., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01032 · Cited by 37
Voltage-gated sodium channels viewed through a structural biology lens
Clairfeuille, T., Xu, H., Koth, C. M., & Payandeh, J. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.11.022 · Cited by 37
Sakata, K., Wang, Y., Urabe, D., & Inoue, M. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b03482 · Cited by 35
Dual-pocket inhibition of Na v channels by the antiepileptic drug lamotrigine
Huang, J., Fan, X., Jin, X., Teng, L., & Yan, N. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309773120 · Cited by 35
Bellis, M. D., Carbonara, R., Roussel, J., Farinato, A., Massari, A. M., Pierno, S., Muraglia, M., Corbo, F., Franchini, C., Carratù, M. R., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.013 · Cited by 35
Metadata
- Authors
- de Lera Ruiz, M., & Kraus, R. L.
- Affiliations
- Merck Research Laboratories , 770 Sumneytown Pike , , ,
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- ORCID
- Kraus, Richard L.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-30
- Volume
- 58
- Issue
- 18
- Pages
- 7093-7118
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2031713143
- Cited by
- 548
- References
- 203
- Citations by year
- 2026: 42 · 2025: 58 · 2024: 70 · 2023: 80 · 2022: 71 · 2021: 50 · 2020: 39 · 2019: 37 · 2018: 40 · 2017: 33 · 2016: 20 · 2015: 8
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Medicinal Chemistry (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- voltage-gated sodium channels, Nav1.7, sodium channel structure, sodium channel toxins, ligand binding sites, nociception, pain
- MeSH terms
- Animals, Biological Products, Cardiovascular Diseases, Clinical Trials as Topic, Drug Industry, Epilepsy, Humans, Ligands, Mutation, Neoplasms, Neuromuscular Diseases, Pain, Respiratory Tract Diseases, Ion Channel Gating, Protein Structure, Tertiary, Protein Subunits, Channelopathies, Voltage-Gated Sodium Channels, Voltage-Gated Sodium Channel Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.